Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 312-322

  Jeong, Soo Ryeong ^a   Kwon, Min Jung ^a   Lee, Hwan Goo ^a   Joe, Eun Hye ^a   Lee, Jae Ho ^a   Kim, Sung Soo ^a   Suh Kim, Haeyoung ^a   Kim, Byung G ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Chondroitin sulfate proteoglycans; Glial scar; Hepatocyte growth factor; Spinal cord injury; Transforming growth factor beta

Indexed keywords

GLYCOSAMINOGLYCAN; NEUROCAN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG MECHANISM; EX VIVO GENE TRANSFER; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEPATOCYTE GROWTH FACTOR GENE; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SCAR FORMATION; SPINAL CORD INJURY; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; AXONS; CELLS, CULTURED; CEREBRAL CORTEX; CHONDROITIN SULFATE PROTEOGLYCANS; CICATRIX; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; HAND STRENGTH; HEPATOCYTE GROWTH FACTOR; HUMANS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84856231980     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.10.021     Document Type: Article

References (60)

1. Alilain W.J., Horn K.P., Hu H., Dick T.E., Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011, 475:196-200.
2. Asher R.A., Morgenstern D.A., Fidler P.S., Adcock K.H., Oohira A., Braistead J.E., Levine J.M., Margolis R.U., Rogers J.H., Fawcett J.W. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 2000, 20:2427-2438.
3. Bevan D., Gherardi E., Fan T.-P., Edwards D., Warn R. Diverse and potent activities of HGF/SF in skin wound repair. J. Pathol. 2004, 203:831-838.
4. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
5. Brahmachari S., Fung Y.K., Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 2006, 26:4930-4939.
6. Bundesen L.Q., Scheel T.A., Bregman B.S., Kromer L.F. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J. Neurosci. 2003, 23:7789-7800.
7. Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., Brook G.A. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord 2008, 46:364-371.
8. Caggiano A.O., Zimber M.P., Ganguly A., Blight A.R., Gruskin E.A. Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J. Neurotrauma 2005, 22:226-239.
9. Davies S.J., Field P.M., Raisman G. Regeneration of cut adult axons fails even in the presence of continuous aligned glial pathways. Exp. Neurol. 1996, 142:203-216.
10. Ebens A., Brose K., Leonardo E.D., Hanson M.G., Bladt F., Birchmeier C., Barres B.A., Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996, 17:1157-1172.
11. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
12. Gong R., Rifai A., Tolbert E.M., Centracchio J.N., Dworkin L.D. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J. Am. Soc. Nephrol. 2003, 14:3047-3060.
13. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J. Neurosci. Res. 1996, 43:554-564.
14. Hellal F., Hurtado A., Ruschel J., Flynn K.C., Laskowski C.J., Umlauf M., Kapitein L.C., Strikis D., Lemmon V., Bixby J., Hoogenraad C.C., Bradke F. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 2011, 331:928-931.
15. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 1993, 164:229-232.
16. Higashiyama R., Inagaki Y., Hong Y.Y., Kushida M., Nakao S., Niioka M., Watanabe T., Okano H., Matsuzaki Y., Shiota G., Okazaki I. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007, 45:213-222.
17. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 2003, 182:399-411.
18. Kadoyama K., Funakoshi H., Ohya W., Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci. Res. 2007, 59:446-456.
19. Kim B.G., Dai H.N., Lynskey J.V., McAtee M., Bregman B.S. Degradation of chondroitin sulfate proteoglycans potentiates transplant-mediated axonal remodeling and functional recovery after spinal cord injury in adult rats. J. Comp. Neurol. 2006, 497:182-198.
20. Kim S.S., Yoo S.W., Park T.S., Ahn S.C., Jeong H.S., Kim J.W., Chang D.Y., Cho K.G., Kim S.U., Huh Y., Lee J.E., Lee S.Y., Lee Y.D., Suh-Kim H. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 2008, 26:2217-2228.
21. Kitamura K., Iwanami A., Nakamura M., Yamane J., Watanabe K., Suzuki Y., Miyazawa D., Shibata S., Funakoshi H., Miyatake S., Coffin R.S., Nakamura T., Toyama Y., Okano H. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J. Neurosci. Res. 2007, 85:2332-2342.
22. Krasnoselsky A., Massay M.J., DeFrances M.C., Michalopoulos G., Zarnegar R., Ratner N. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J. Neurosci. 1994, 14:7284-7290.
23. Lagord C., Berry M., Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol. Cell. Neurosci. 2002, 20:69-92.
24. Liu Y., Yang J. Hepatocyte growth factor: new arsenal in the fights against renal fibrosis?. Kidney Int. 2006, 70:238-240.
25. Logan A., Berry M., Gonzalez A.M., Frautschy S.A., Sporn M.B., Baird A. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 1994, 6:355-363.
26. Logan A., Green J., Hunter A., Jackson R., Berry M. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur. J. Neurosci. 1999, 11:2367-2374.
27. Ma P.C., Maulik G., Christensen J., Salgia R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 2003, 22:309-325.
28. Maina F., Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci. 1999, 2:213-217.
29. Matsumoto K., Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog. 1992, 3:27-54.
30. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 1999, 19:10778-10788.
31. Meyer O.A., Tilson H.A., Byrd W.C., Riley M.T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1:233-236.
32. Mizuno S., Kurosawa T., Matsumoto K., Mizuno-Horikawa Y., Okamoto M., Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 1998, 101:1827-1834.
33. Mizuno S., Matsumoto K., Kurosawa T., Mizuno-Horikawa Y., Nakamura T. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int. 2000, 57:937-948.
34. Moon L.D., Fawcett J.W. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur. J. Neurosci. 2001, 14:1667-1677.
35. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
36. Nakamura T., Sakata R., Ueno T., Sata M., Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000, 32:247-255.
37. Ohya W., Funakoshi H., Kurosawa T., Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res. 2007, 1147:51-65.
38. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
39. Reier P.J., Houle J.D. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 1988, 47:87-138.
40. Reilly J.F., Maher P.A., Kumari V.G. Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia 1998, 22:202-210.
41. Ribotta M.G., Menet V., Privat A. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. Acta Neurochir. Suppl. 2004, 89:87-92.
42. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20:570-577.
43. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:235-241.
44. Schucht P., Raineteau O., Schwab M.E., Fouad K. Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp. Neurol. 2002, 176:143-153.
45. Semple-Rowland S.L., Mahatme A., Popovich P.G., Green D.A., Hassler G., Stokes B.T., Streit W.J. Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR. J. Neurotrauma 1995, 12:1003-1014.
46. Shang J., Deguchi K., Ohta Y., Liu N., Zhang X., Tian F., Yamashita T., Ikeda Y., Matsuura T., Funakoshi H., Nakamura T., Abe K. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J. Neurosci. Res. 2011, 89:86-95.
47. Shimazaki K., Yoshida K., Hirose Y., Ishimori H., Katayama M., Kawase T. Cytokines regulate c-Met expression in cultured astrocytes. Brain Res. 2003, 962:105-110.
48. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
49. Smith G.M., Strunz C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 2005, 52:209-218.
50. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 1998, 152:74-87.
51. Sun W., Funakoshi H., Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 2002, 22:6537-6548.
52. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71:427-444.
53. Tester N.J., Howland D.R. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp. Neurol. 2008, 209:483-496.
54. Tom V.J., Houle J.D. Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge. Exp. Neurol. 2008, 211:315-319.
55. Wilson J.X., Dixon S.J. Ascorbic acid transport in mouse and rat astrocytes is reversibly inhibited by furosemide, SITS, and DIDS. Neurochem. Res. 1989, 14:1169-1175.
56. Yamamoto Y., Livet J., Pollock R.A., Garces A., Arce V., deLapeyriere O., Henderson C.E. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development 1997, 124:2903-2913.
57. Yan H., Rivkees S.A. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J. Neurosci. Res. 2002, 69:597-606.
58. Yang J., Dai C., Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am. J. Pathol. 2003, 163:621-632.
59. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
60. Zhao M.Z., Nonoguchi N., Ikeda N., Watanabe T., Furutama D., Miyazawa D., Funakoshi H., Kajimoto Y., Nakamura T., Dezawa M., Shibata M.A., Otsuki Y., Coffin R.S., Liu W.D., Kuroiwa T., Miyatake S. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J. Cereb. Blood Flow Metab. 2006, 26:1176-1188.